Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Homatropine
Drug ID BADD_D01075
Description Homatropine is an anticholinergic drug that acts as an antagonist at muscarinic acetylcholine receptors. It is present in antitussives, under the trade name Hycodan, in combination with hydrocodone (dihydrocodeinone) bitartrate indicated for the symptomatic relief of cough as oral tablets or solutions. Homatropine is included in subtherapeutic amounts as homatropine methylbromide to discourage deliberate overdosage. Homatropine hydrobromide has been administered as ophthalmic solutions as a cycloplegic to temporarily paralyze accomodation, and to induce mydriasis (the dilation of the pupil); however such therapeutic use has not been approved by the FDA to be safe and effective.
Indications and Usage
Marketing Status Not Available
ATC Code S01FA05
DrugBank ID DB11181
KEGG ID C07814
MeSH ID C100236
PubChem ID 688024
TTD Drug ID Not Available
NDC Product Code Not Available
Synonyms homatropine | homatropine, (3(S)-endo)-isomer | homatropine, exo-(+-)-isomer | I - Homatrine | Isopto Homatropine | Minims-Homatropin | AK-Homatropine | Homatropin - POS | homatropine hydrobromide, (endo-(+-)-isomer) | homatropine hydrochloride, (endo-(+-)-isomer) | homatropine sulfate (1:1), (3(R)-endo)-isomer | homatropine sulfate (1:1), (3(S)-endo)-isomer | homatropine sulfate (2:1), endo-isomer | Minims-Homatropine Hydrobromide
Chemical Information
Molecular Formula C16H21NO3
CAS Registry Number 87-00-3
SMILES CN1C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Pain08.01.08.004--
Paralysis17.01.04.004--Not Available
Photophobia17.17.02.006; 06.01.01.004--
Rash23.03.13.001--Not Available
Respiratory depression22.02.01.010; 17.02.05.047--Not Available
Retrograde amnesia19.20.01.006; 17.03.02.006--Not Available
Seizure17.12.03.001--
Somnolence19.02.05.003; 17.02.04.006--
Tachycardia02.03.02.007--Not Available
Thirst14.03.02.007; 08.01.09.021--Not Available
Trisomy 2119.21.06.005; 17.03.07.005; 03.12.01.003; 02.08.02.003--Not Available
Urinary retention20.02.02.011--
Vision blurred17.17.01.010; 06.02.06.007--
Eye oedema06.08.03.013--Not Available
Vasodilation procedure25.03.01.001--Not Available
Cardiac disorder02.01.01.003--Not Available
Mental disorder19.07.01.002--Not Available
Psychotic disorder19.03.01.002--
Pulmonary function test decreased13.19.01.001--Not Available
Brain injury19.07.03.007; 17.11.01.003--Not Available
The 2th Page    First    Pre   2    Total 2 Pages